Dr. Arjun Kumar Chagarlamudi, MD

Dr. Chagarlamudi practices at Hillsboro Medical Center in Hillsboro, Oregon, part of Hillsboro Medical Center.

Dr. Chagarlamudi's NPI, 1568699932, was assigned on June 12, 2009. Dr. Chagarlamudi holds Oregon license MD177109.

Dr. Chagarlamudi's primary practice is Hillsboro Medical Center, at 335 SE 8th Avenue, Hillsboro, OR 97123 in Washington County. The practice phone is (503) 681-1111.

Dr. Chagarlamudi's primary practice is Hillsboro Medical Center in Hillsboro, Oregon, part of Hillsboro Medical Center. Dr. Chagarlamudi is also affiliated with OHSU Hospital. The medical group on file is Kaiser Permanente Northwest. Dmand AI also links Dr. Chagarlamudi to 1 more hospital, 8 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chagarlamudi practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Chagarlamudi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Chagarlamudi is licensed in Oregon.

CMS data shows 2,019 Medicare services from Dr. Chagarlamudi across 18 procedure codes in 2024, for 1,020 Medicare patients. Medicare paid $45,512 for them.

CMS counts 1,020 Medicare patients who saw Dr. Chagarlamudi in 2024. The largest group is 65 to 74, with 433 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chagarlamudi's median patient age at 74, with 53% women.

In 2024, Dr. Chagarlamudi wrote 2,474 Medicare Part D claims for 483 patients. 84% of them were for generic drugs. CMS names the drug for 2,331 of them, across 33 drugs with 11 or more claims each, at $425,598 in total drug cost. In 2023, CMS named 1,381 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Chagarlamudi for performance year 2024, reported through an alternative payment model (APM). Dr. Chagarlamudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chagarlamudi as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Chagarlamudi, published from 2013 to 2022. Dr. Chagarlamudi's most frequent co-authors are Ashesh N. Buch, MD and Christopher Paul Gregory, MD.

CMS Open Payments shows 232 general payments to Dr. Chagarlamudi from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $616.